Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections: A Diagnostic Accuracy Study.

Nguyen MH, Clancy CJ, Pasculle AW, Pappas PG, Alangaden G, Pankey GA, Schmitt BH, Rasool A, Weinstein MP, Widen R, Hernandez DR, Wolk DM, Walsh TJ, Perfect JR, Wilson MN, Mylonakis E.

Ann Intern Med. 2019 Jun 18;170(12):845-852. doi: 10.7326/M18-2772. Epub 2019 May 14.

PMID:
31083728
2.

Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.

Thomas VM, Brown RM, Ashcraft DS, Pankey GA.

Int J Antimicrob Agents. 2019 May;53(5):663-668. doi: 10.1016/j.ijantimicag.2019.03.009. Epub 2019 Mar 14.

PMID:
30880230
3.

In vitro synergy with fluconazole plus doxycycline or tigecycline against clinical Candida glabrata isolates.

Hooper RW, Ashcraft DS, Pankey GA.

Med Mycol. 2019 Jan 1;57(1):122-126. doi: 10.1093/mmy/myy008.

PMID:
29618039
4.
5.

Evaluation of the Rapid Polymyxin NP Test for Polymyxin B Resistance Detection Using Enterobacter cloacae and Enterobacter aerogenes Isolates.

Simar S, Sibley D, Ashcraft D, Pankey G.

J Clin Microbiol. 2017 Oct;55(10):3016-3020. doi: 10.1128/JCM.00934-17. Epub 2017 Jul 26.

6.

Tuberculous Otomastoiditis.

Hand JM, Pankey GA.

Microbiol Spectr. 2016 Dec;4(6). doi: 10.1128/microbiolspec.TNMI7-0020-2016. Review.

PMID:
28084203
7.

In vitro Synergistic Activity of Caspofungin Plus Polymyxin B Against Fluconazole-Resistant Candida glabrata.

Adams EK, Ashcraft DS, Pankey GA.

Am J Med Sci. 2016 Mar;351(3):265-70. doi: 10.1016/j.amjms.2015.12.014.

PMID:
26992255
8.

Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program.

Deshpande LM, Ashcraft DS, Kahn HP, Pankey G, Jones RN, Farrell DJ, Mendes RE.

Antimicrob Agents Chemother. 2015 Oct;59(10):6256-61. doi: 10.1128/AAC.01473-15. Epub 2015 Jul 27.

9.

Update on the emerging role of telavancin in hospital-acquired infections.

Nnedu ON, Pankey GA.

Ther Clin Risk Manag. 2015 Apr 13;11:605-10. doi: 10.2147/TCRM.S57376. eCollection 2015. Review.

10.

Time-kill assay and Etest evaluation for synergy with polymyxin B and fluconazole against Candida glabrata.

Pankey G, Ashcraft D, Kahn H, Ismail A.

Antimicrob Agents Chemother. 2014 Oct;58(10):5795-800. doi: 10.1128/AAC.03035-14. Epub 2014 Jul 21.

11.

Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment.

Schieffelin JS, Garcia-Diaz JB, Loss GE Jr, Beckman EN, Keller RA, Staffeld-Coit C, Garces JC, Pankey GA.

Transpl Infect Dis. 2014 Apr;16(2):270-8. doi: 10.1111/tid.12197. Epub 2014 Mar 17.

PMID:
24628809
12.

Comparison of 3 Etest(®) methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species.

Pankey GA, Ashcraft DS, Dornelles A.

Diagn Microbiol Infect Dis. 2013 Nov;77(3):220-6. doi: 10.1016/j.diagmicrobio.2013.07.006. Epub 2013 Aug 28.

PMID:
23993213
14.

IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults.

Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJ, Hicks LA, Pankey GA, Seleznick M, Volturo G, Wald ER, File TM Jr; Infectious Diseases Society of America.

Clin Infect Dis. 2012 Apr;54(8):e72-e112. doi: 10.1093/cid/cir1043. Epub 2012 Mar 20.

PMID:
22438350
15.

Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.

Pankey GA, Ashcraft DS.

Diagn Microbiol Infect Dis. 2011 Aug;70(4):561-4. doi: 10.1016/j.diagmicrobio.2011.05.003.

PMID:
21767715
16.

In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia.

Pankey GA, Ashcraft DS.

Diagn Microbiol Infect Dis. 2010 Jul;67(3):297-300. doi: 10.1016/j.diagmicrobio.2010.02.015.

PMID:
20542209
17.

In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa.

Chachanidze V, Curbelo-Irizarry A, Ashcraft D, Pankey G.

Interdiscip Perspect Infect Dis. 2009;2009:984934. doi: 10.1155/2009/984934. Epub 2009 Nov 8.

18.

Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006.

Sader HS, Fey PD, Limaye AP, Madinger N, Pankey G, Rahal J, Rybak MJ, Snydman DR, Steed LL, Waites K, Jones RN.

Antimicrob Agents Chemother. 2009 Oct;53(10):4127-32. doi: 10.1128/AAC.00616-09. Epub 2009 Jul 27. Erratum in: Antimicrob Agents Chemother. 2010 Mar;54(3):1383. Fish, Douglas N [corrected to Madinger, Nancy].

19.

In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time-kill assay.

Pankey GA, Ashcraft DS.

Diagn Microbiol Infect Dis. 2009 Jul;64(3):300-4. doi: 10.1016/j.diagmicrobio.2009.03.023.

PMID:
19501791
20.

A man presenting with nodules on hands and elbows.

Curbelo A, Pankey GA.

Clin Infect Dis. 2009 Apr 15;48(8):1114-5, 1160-1. doi: 10.1086/597462. No abstract available.

PMID:
19292636
21.

The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest and time-kill assay.

Pankey GA, Ashcraft DS.

Diagn Microbiol Infect Dis. 2009 Feb;63(2):228-32. doi: 10.1016/j.diagmicrobio.2008.11.002.

PMID:
19150711
22.
23.

Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease.

Baddley JW, Perfect JR, Oster RA, Larsen RA, Pankey GA, Henderson H, Haas DW, Kauffman CA, Patel R, Zaas AK, Pappas PG.

Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):937-43. doi: 10.1007/s10096-008-0529-z. Epub 2008 May 1.

PMID:
18449582
24.

Tigecycline in critical care.

Mullangi PK, Pankey GA.

Crit Care Clin. 2008 Apr;24(2):365-75, x. doi: 10.1016/j.ccc.2007.12.007. Review.

PMID:
18361951
25.

Study of common functional genetic polymorphisms of FCGR2A, 3A and 3B genes and the risk for cryptococcosis in HIV-uninfected patients.

Meletiadis J, Walsh TJ, Choi EH, Pappas PG, Ennis D, Douglas J, Pankey GA, Larsen RA, Hamill RJ, Chanock S.

Med Mycol. 2007 Sep;45(6):513-8.

PMID:
17710620
26.

Tigecycline: a single antibiotic for polymicrobial infections.

Pankey GA, Steele RW.

Pediatr Infect Dis J. 2007 Jan;26(1):77-8. Review. No abstract available.

PMID:
17195711
27.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T.

Clin Infect Dis. 2006 Oct 15;43(8):1031-9. Epub 2006 Sep 13. No abstract available. Erratum in: Clin Infect Dis. 2007 Mar 15;44(6):894.

PMID:
16983616
28.

Salvage treatment of histoplasmosis with posaconazole.

Restrepo A, Tobón A, Clark B, Graham DR, Corcoran G, Bradsher RW, Goldman M, Pankey G, Moore T, Negroni R, Graybill JR.

J Infect. 2007 Apr;54(4):319-27. Epub 2006 Jul 7.

PMID:
16824608
29.
30.

Tigecycline.

Pankey GA.

J Antimicrob Chemother. 2005 Sep;56(3):470-80. Epub 2005 Jul 22. Review.

PMID:
16040625
31.
32.

The importance of bactericidal drugs: future directions in infectious disease.

Finberg RW, Moellering RC, Tally FP, Craig WA, Pankey GA, Dellinger EP, West MA, Joshi M, Linden PK, Rolston KV, Rotschafer JC, Rybak MJ.

Clin Infect Dis. 2004 Nov 1;39(9):1314-20. Epub 2004 Oct 7. Review.

PMID:
15494908
33.

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.

Pankey GA, Sabath LD.

Clin Infect Dis. 2004 Mar 15;38(6):864-70. Epub 2004 Mar 1. Review.

PMID:
14999632
34.

West nile virus: current perspectives.

Prakash O, Pankey G.

Ochsner J. 2003 Summer;5(3):21-5. No abstract available.

35.
36.

Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin.

Sher LD, Poole MD, Von Seggern K, Wikler MA, Nicholson SC, Pankey GA.

Otolaryngol Head Neck Surg. 2002 Sep;127(3):182-9.

PMID:
12297808
37.

Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.

Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, Henderson H, Kauffman CA, Haas DW, Saccente M, Hamill RJ, Holloway MS, Warren RM, Dismukes WE.

Clin Infect Dis. 2001 Sep 1;33(5):690-9. Epub 2001 Jul 26.

PMID:
11477526
38.

Deep dermatophytosis: report of 2 cases and review of the literature.

Chastain MA, Reed RJ, Pankey GA.

Cutis. 2001 Jun;67(6):457-62. Review.

PMID:
11419016
39.

Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor.

Garcia-Diaz JB, Palau L, Pankey GA.

Clin Infect Dis. 2001 Jun 15;32(12):e145-50. Epub 2001 May 7.

PMID:
11360225
40.

HIV Eradication: Progress and Challenges.

Prakash O, Pankey G.

Ochsner J. 2001 Apr;3(2):98-101. No abstract available.

41.
42.

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.

Stevens DA, Kan VL, Judson MA, Morrison VA, Dummer S, Denning DW, Bennett JE, Walsh TJ, Patterson TF, Pankey GA.

Clin Infect Dis. 2000 Apr;30(4):696-709. Epub 2000 Apr 20.

PMID:
10770732
43.
44.

Hepatitis E seroconversion in United States travelers abroad.

Ooi WW, Gawoski JM, Yarbough PO, Pankey GA.

Am J Trop Med Hyg. 1999 Nov;61(5):822-4.

PMID:
10586918
45.

Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management.

Bonham CA, Dominguez EA, Fukui MB, Paterson DL, Pankey GA, Wagener MM, Fung JJ, Singh N.

Transplantation. 1998 Dec 27;66(12):1596-604.

PMID:
9884245
46.

Mediterranean Spotted Fever in Travelers from the United States.

Palau LA, Pankey GA.

J Travel Med. 1997 Dec 1;4(4):179-182.

47.

A multicenter study of the prevalence and susceptibility patterns of isolates of Streptococcus pneumoniae with reduced susceptibility to penicillin G in Louisiana.

Aldridge KE, Ashcraft DS, O'Cain P, Sanders CV, Janney A, Brown W, Silberman R, Pankey GK.

Am J Med Sci. 1998 Oct;316(4):277-84.

PMID:
9766490
49.

Invasive aspergillosis in liver transplant recipients in the 1990s.

Singh N, Arnow PM, Bonham A, Dominguez E, Paterson DL, Pankey GA, Wagener MM, Yu VL.

Transplantation. 1997 Sep 15;64(5):716-20.

PMID:
9311708
50.

Recurrent iritis after intravenous administration of cidofovir.

Palau LA, Tufty GT, Pankey GA.

Clin Infect Dis. 1997 Aug;25(2):337-8. No abstract available.

PMID:
9332544

Supplemental Content

Loading ...
Support Center